| Astrocytoma, IDH-Mutant, Grade 4 studied in …STUDIED_INderived10 of 16show all (up to 200) |
|---|
| → studied in | NCT07831369Phase 2 · recruiting VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma · condition mapped ONTOLOGY_EXACT · 16 trials mapped (13 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860594Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma · condition mapped CURATED_BROADER · 16 trials mapped (13 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145115Phase 2 · active not recruiting A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden · condition mapped ONTOLOGY_EXACT · 16 trials mapped (13 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303519Phase 3 · recruiting SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) · condition mapped ONTOLOGY_EXACT · 16 trials mapped (13 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07544992Phase 1 · recruiting Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas · condition mapped CURATED_BROADER · 16 trials mapped (13 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06815029Phase 1 · recruiting Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma · condition mapped CURATED_BROADER · 16 trials mapped (13 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07673679completed GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4 · condition mapped ONTOLOGY_EXACT · 16 trials mapped (13 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07468136Phase 1/Phase 2 · recruiting Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas · condition mapped ONTOLOGY_EXACT · 16 trials mapped (13 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565521Phase 2 · active not recruiting UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly · condition mapped ALIAS · 16 trials mapped (13 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07301268Phase 2 · recruiting GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma · condition mapped CURATED_BROADER · 16 trials mapped (13 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |